SuperworthQuest Diagnostics EPS DGX
Diluted earnings per share by quarter and over the last twelve months, from 2008.
- Last 12 months, to Sep 30, 2026
- $10.03
- Latest quarter, Q3 FY26
- $2.78
- +29% on a year earlier
- Fiscal year 2025
- $8.74
- +14% on the year before
Quest Diagnostics' earnings per share was $10.03 over the twelve months to Sep 30, 2026, up 18% on a year earlier.
In its latest quarter, Q3 FY26, it was $2.78, up 29% on the same quarter a year before.
Over the five fiscal years to FY2025 it shrank 3% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $8.74 | +14% |
| FY2024 | $7.65 | +1% |
| FY2023 | $7.54 | −5% |
| FY2022 | $7.93 | −49% |
| FY2021 | $15.56 | +49% |
| FY2020 | $10.44 | +66% |
| FY2019 | $6.28 | +19% |
| FY2018 | $5.29 | −4% |
| FY2017 | $5.50 | +22% |
| FY2016 | $4.51 | −7% |
| FY2015 | $4.87 | +28% |
| FY2014 | $3.80 | −32% |
| FY2013 | $5.57 | +61% |
| FY2012 | $3.45 | +17% |
| FY2011 | $2.95 | −27% |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q3 FY26 | $2.78 | +29% | $10.03 | |
| Q2 FY26 | $2.84 | +15% | $9.41 | |
| Q1 FY26 | $2.24 | +15% | $9.04 | |
| Q4 FY25 | $2.17 | +14% | $8.74 | |
| Q3 FY25 | $2.16 | +9% | $8.48 | |
| Q2 FY25 | $2.47 | +22% | $8.31 | |
| Q1 FY25 | $1.94 | +13% | $7.87 | |
| Q4 FY24 | $1.91 | +9% | $7.65 | |
| Q3 FY24 | $1.99 | +2% | $7.49 | |
| Q2 FY24 | $2.03 | −1% | $7.46 | |
| Q1 FY24 | $1.72 | −3% | $7.48 | |
| Q4 FY23 | $1.75 | +99% | $7.54 |
Against its peers
Companies in Medical - Diagnostics & Research nearest Quest Diagnostics' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| DGXQuest Diagnostics | $9.41 | +18% a year |
| LHLabcorp | $12.09 | +33% a year |
| MTDMettler-Toledo International | $44.42 | +12% a year |
| MEDPMedpace | $17.05 | +27% a year |
| RVTYRevvity | $2.10 | −11% a year |
| ILMNIllumina | $5.38 | −32% a year |
| IDXXIDEXX Laboratories | $14.22 | +18% a year |
| WATWaters | $4.01 | −64% a year |
| IQVIQVIA | $8.06 | +17% a year |
| AAgilent Technologies | $5.09 | +19% a year |
| BIOBio-Rad Laboratories | $8.25 | −30% a year |
| Peer median | $8.15 |
Where Quest Diagnostics ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Quest Diagnostics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.